BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28258008)

  • 1. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
    Peterson BG; Tan KW; Osa-Andrews B; Iram SH
    Pharmacol Res; 2017 May; 119():313-326. PubMed ID: 28258008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
    Sampson A; Peterson BG; Tan KW; Iram SH
    Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
    Cheung L; Flemming CL; Watt F; Masada N; Yu DM; Huynh T; Conseil G; Tivnan A; Polinsky A; Gudkov AV; Munoz MA; Vishvanath A; Cooper DM; Henderson MJ; Cole SP; Fletcher JI; Haber M; Norris MD
    Biochem Pharmacol; 2014 Sep; 91(1):97-108. PubMed ID: 24973542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.
    Cheung L; Yu DM; Neiron Z; Failes TW; Arndt GM; Fletcher JI
    Biochem Pharmacol; 2015 Feb; 93(3):380-8. PubMed ID: 25462817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
    Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells.
    Chaisit T; Siripong P; Jianmongkol S
    Eur J Pharmacol; 2017 Jan; 795():50-57. PubMed ID: 27916559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells.
    Tan KW; Sampson A; Osa-Andrews B; Iram SH
    Drug Metab Dispos; 2018 Dec; 46(12):1856-1866. PubMed ID: 30232176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
    Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):69-79. PubMed ID: 27810353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.
    Ma SL; Hu YP; Wang F; Huang ZC; Chen YF; Wang XK; Fu LW
    Mol Med; 2014 Sep; 20(1):390-9. PubMed ID: 25105301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
    Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
    Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
    Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.
    Yang AK; Zhou ZW; Wei MQ; Liu JP; Zhou SF
    Curr Top Med Chem; 2010; 10(17):1732-56. PubMed ID: 20645920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
    de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
    Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters.
    Ivnitski-Steele I; Larson RS; Lovato DM; Khawaja HM; Winter SS; Oprea TI; Sklar LA; Edwards BS
    Assay Drug Dev Technol; 2008 Apr; 6(2):263-76. PubMed ID: 18205550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    J Med Chem; 2016 Apr; 59(7):3018-33. PubMed ID: 26943020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.
    Zhang H; Patel A; Ma SL; Li XJ; Zhang YK; Yang PQ; Kathawala RJ; Wang YJ; Anreddy N; Fu LW; Chen ZS
    Br J Pharmacol; 2014 Dec; 171(24):5845-57. PubMed ID: 25164592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.
    Xu X; Zhang Y; Li W; Miao H; Zhang H; Zhou Y; Li Z; You Q; Zhao L; Guo Q
    Biochem Pharmacol; 2014 Nov; 92(2):220-34. PubMed ID: 25264278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.